Examine the World Wound Care Products Market.NEW YORK New York, state, United StatesNew York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. World Wound Care Products Market http://www.reportlinker.com/p092552/World-Wound-Care-Products-Market.html This report analyzes the worldwide markets for Wound Care Products in Millions of US$. The major product segments analyzed are Traditional {Wound Management Products (Adhesive Bandages, Topical Ointments ointments, n.pl semisolid, non–water-based treatments that are not water-soluble and that create protective films to prevent dehydration of the skin. , & Gauzes); and Wound Closure Products (Internal Staplers, Skin Staplers, Surgical/Ligature Clips, Vascular Clips, & Sutures)}; Advanced {Moist Wound Healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by Products (Alginate alginate /al·gi·nate/ (al´ji-nat) a salt of alginic acid; water-soluble alginates are useful as materials for dental impressions. Dressings, Film Dressings, Foam Dressings, Hydrocolloid Dressings, & Hydrogel hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. Dressings); Active Wound Healing Products (Skin replacements, Collagen Dressings, & Growth Factors); Debriding Products; Cleansers; and Sealants}, and Antimicrobial Dressings Market (Silver Anti-Microbial Dressings, & Non-Silver Anti-Microbial Dressings). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 225 companies including many key and niche players worldwide such as 3M, Beiersdorf AG, Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were , ConvaTec, BSN BSN abbr. Bachelor of Science in Nursing Medical GmbH & Co. KG, Carrington Laboratories, Coloplast A/S, C.R. Bard Inc., Covidien Ltd, Derma der·ma n. See dermis. derma the corium, or true skin. Sciences Inc, FibroGen Inc, FibroGen Europe, Forticell Bioscience, Inc., I-Flow Corp, AcryMed, Johnson & Johnson, Ethicon, CLOSURE Medical Corporation, Kensey Nash Corp, Kinetic Concepts, Inc., LAM Pharmaceutical, Corp., Medline, Molnlycke Health Care AB, Organogenesis organogenesis /or·ga·no·gen·e·sis/ (or?gah-no-jen´e-sis) the origin and development of organs.organogenet´ic or·gan·o·gen·e·sis n. The formation and development of the organs of living things. Inc, ProCyte Corporation, Smith & Nephew Plc, and Trumed Technologies. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. research and reported select online sources. WOUND CARE PRODUCTS MCP-3230 A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level Reporting Level A level of ownership of a specific futures position wherein the holders exceed the stated amounts and are required by the CFTC to submit daily reports. Also known as reporting limit. I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Traditional Products I-4 Wound Management Products I-4 Adhesive Bandages I-4 Plasters I-5 Topical Ointments I-5 Gauzes I-5 Wound Closure Products I-5 Staplers I-5 Clips I-5 Sutures I-5 Advanced Products I-5 Moist Wound Healing Products I-6 Alginates I-6 Calcium Alginates I-6 Film Dressings I-6 Transparent Films I-6 Foam Dressings I-7 Hydrocolloid Dressings I-7 Hydrogels I-7 Active Wound Healing Products I-7 Skin Replacements I-7 Collagen I-8 Growth Factor Products I-8 Debriding Products I-8 Cleansing Products I-8 Sealants I-9 Antimicrobial Dressings I-9 Silver Antimicrobial Dressings I-9 Non-Silver Antimicrobial Dressings I-9 II. EXECUTIVE SUMMARY 1. Industry Overview II-1 Wound Care: Evolves from an Art to a Science II-1 Market Outlook II-1 Rapid Development in Advanced Wound Care II-1 2. Global Wound Care Market II-3 Analysis by Geographic Region II-3 United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. - Largest and Fastest Market II-3 Europe - Second Largest Wound Care Market II-3 Other Markets II-3 Analysis by Product Group/Segment II-3 Traditional Wound Care Products Experiencing Lackluster Growth II-3 Advanced Products to Drive Growth II-4 3. Trends and Issues II-5 Key Market Trends Impacting Wound Care Market II-5 Tissue Engineering - Transforming Wound Care II-5 Biotechnology: The New Frontier New Frontier President John F. Kennedy’s legislative program, encompassing such areas as civil rights, the economy, and foreign relations. [Am. Hist.: WB, K:212] See : Aid, Governmental II-6 Advances in Molecular Science Favor Wound Care II-7 The New Paradigm New Paradigm In the investing world, a totally new way of doing things that has a huge effect on business. Notes: The word "paradigm" is defined as a pattern or model, and it has been used in science to refer to a theoretical framework. of "Collaboration" II-7 Artificial Skin Becomes a Reality II-7 Hybrid Dressings Gain Prominence II-8 Wound Sealing wound sealing, v moving the hands over an injury to facilitate energy gathering and then holding them above the injury for one minute. Market II-8 Wound Healing through Therapeutic Angiogenesis Therapeutic angiogenesis is an experimental area of treatment of ischemia, the condition which associated with decrease in blood supply to certain body organs, tissue or part. This usually caused by constriction or obstruction of the blood vessels. : A Shift from Passive Treatment II-9 Wound Care at Home: A Growing Trend II-9 Minimally Invasive Procedures Dampen Wound Closure Market II-9 Demographics and Chronic Wound Treatment Drive Wound Care Market II-9 Regranex Accelerates Growth Factors' Growth II-9 Silver Dressings: An Emerging Trend in Wound Care II-10 Medihoney - A Natural Way to Treat Antibiotic-Resistant Wounds II-10 Complicated Regulatory Process for Pharmacological Agents II-11 4. Competitive Analysis II-12 J&J and Tyco Healthcare Tyco Healthcare was the former healthcare division of Tyco International Ltd. On June 29, 2007 it became a wholly independent publicly traded company named Covidien Ltd. Lead World Wound Care Market II-12 Table 1: Leading Players in Worldwide Wound Care Products Market (2006) - Percentage Breakdown by Value Sales for Johnson & Johnson, Tyco Healthcare, 3M, ConvaTec, Smith & Nephew, BSN Medical, Kinetic Concepts, Inc., and Others (includes corresponding Graph/Chart) II-12 Table 2: Leading Players in Worldwide Advanced Wound Care Products Market (2006) - Percentage Breakdown by Value Sales for Smith & Nephew, Johnson & Johnson, ConvaTec, 3M, Kinetic Concepts, Inc., Coloplast Ltd., Molnlycke Healthcare, and Others (includes corresponding Graph/Chart) II-13 5. Product Overview II-14 Wound Care - A Costly Proposition II-14 Evolution of Wound Care Market II-14 Classification of Wound Care Products II-14 Traditional Products II-14 Wound Management Products II-14 Adhesive Bandages II-14 Plasters II-15 Topical Ointments II-15 Gauzes II-15 Wound Closure Products II-16 Staplers II-16 Clips II-16 Sutures II-16 Advanced Products II-17 Moist Wound Healing Products II-17 Market Drivers II-17 Market Impediments II-17 Advantages of Moisture Retentive re·ten·tive adj. 1. Having the quality, power, or capacity of retaining. 2. Having the ability or capacity to retain knowledge or information with ease: a retentive memory. Dressings II-18 Moist Wound Dressings Mainly Utilize Synthetic Materials II-18 Alginates II-19 Calcium Alginates II-19 Alginates - A Market Buoyed by Innovations II-19 Film Dressings II-20 Transparent Films II-20 Foam Dressings II-20 Innovations Revive Declining Market II-21 Hydrocolloid Dressings II-21 Hydrocolloids Losing Share to Newer Dressings... II-21 Hydrocolloid/Alginate Dressings: New Entrants to the Market II-22 Hydrogels II-22 Market Faces Many Challenges II-22 Hydrocolloid Dressings, Films, Foams and Hydrogels - A Comparison II-22 Active Wound Healing Products II-23 Skin Replacements II-23 Market Drivers II-23 Market Impediments II-23 Collagen II-23 In Vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. Culture II-24 Coatings II-24 Tissue Engineering II-25 Multiple Delivery Mechanism II-25 Bioartificial Mediums II-25 Fillers II-25 Growth Factor Products II-25 Autologous autologous /au·tol·o·gous/ (aw-tol´ah-gus) related to self; belonging to the same organism. au·tol·o·gous adj. 1. Growth Factors II-25 Recombinant Growth Factors II-25 Market Drivers II-26 Market Impediments II-26 Debriding Products II-26 Market Drivers II-26 Market Impediments II-26 Cleansing Products II-26 Market Drivers II-27 Market Impediments II-27 Aloe Vera aloe vera n. 1. A species of aloe (Aloe vera) native to the Mediterranean region. 2. The mucilaginous juice or gel obtained from the leaves of this plant, used in pharmaceutical preparations for its soothing and healing II-27 Sealants II-27 Antimicrobial Dressings II-28 Silver Antimicrobial Dressings II-28 Non-Silver Antimicrobial Dressings II-28 6. Types of Wounds II-29 Wound - A Short Description II-29 Acute Wounds II-29 Surgical Incisions II-29 Burns II-29 More Than Just Painful Wounds II-29 Minor Burns II-30 Moderate Burns II-30 Critical Burns II-30 Types of Burns II-30 Chemical Burns II-30 Electrical Burns II-30 Flash Burns II-30 Radiation Burns II-31 Thermal Burns II-31 Other Burn Related Complications II-31 Inhalation Injury II-31 Edema edema (ĭdē`mə), abnormal accumulation of fluid in the body tissues or in the body cavities causing swelling or distention of the affected parts. II-31 Acute Hemolysis hemolysis (hĭmŏl`ĭsĭs), destruction of red blood cells in the bloodstream. Although new red blood cells, or erythrocytes, are continuously created and old ones destroyed, an excessive rate of destruction sometimes occurs. II-31 Acute Renal Failure acute renal failure Acute kidney failure Nephrology An abrupt decline in renal function, triggered by various processes–eg, sepsis, shock, trauma, kidney stones, drug toxicity-aspirin, lithium, substances of abuse, toxins, iodinated radiocontrast. II-31 Infection II-32 Burn Care Protocols II-32 Treating Less Severe Burns II-32 Skin Grafts II-32 Typical Treatment for Burns II-33 Grafting II-33 Cultured Epidermal Epidermal Referring to the thin outermost layer of the skin, itself made up of several layers, that covers and protects the underlying dermis (skin). Mentioned in: Antiangiogenic Therapy, Histiocytosis X epidermal Autograft autograft: see transplantation, medical. II-33 Burn Care Dressings II-33 Cleansing and Debriding Products II-34 Systemic Anti-Infectives II-34 Topical Products II-35 Anesthetics Anesthetics Drugs or methodologies used to make a body area free of sensation or pain. Mentioned in: Appendectomy II-35 Narcotic narcotic, any of a number of substances that have a depressant effect on the nervous system. The chief narcotic drugs are opium, its constituents morphine and codeine, and the morphine derivative heroin. See also drug addiction and drug abuse. Analgesics Analgesics Definition Analgesics are medicines that relieve pain. Purpose Analgesics are those drugs that mainly provide pain relief. and Anesthetics II-35 General Anesthetics II-35 Antibacterial antibacterial /an·ti·bac·te·ri·al/ (-bak-ter´e-al) destroying or suppressing growth or reproduction of bacteria; also, an agent that does this. an·ti·bac·te·ri·al adj. and Antiseptic II-35 Emollients Emollients Petroleum or lanolin-based skin lubricants. Mentioned in: Ichthyosis and Wound-Healing Agents II-35 Burn Ointments II-36 Pressure Relief Beds II-36 Air-Fluidized Beds II-36 Air Wave Beds and Mattresses II-36 Alternating Air Pressure Mattresses II-36 Low Air-Loss Beds II-36 Chronic Wounds II-36 Diabetic Ulcers II-37 Venous Ulcers II-37 Pressure Ulcers II-38 Treating Pressure Ulcers II-38 Cleansing II-38 Debridement Debridement Definition Debridement is the process of removing nonliving tissue from pressure ulcers, burns, and other wounds. Purpose Debridement speeds the healing of pressure ulcers, burns, and other wounds. II-38 Sharp Debridement/Surgical Excision II-38 Mechanical Debridement II-38 Chemical Debridement II-39 Autolytic au·tol·y·sis n. The destruction of tissues or cells of an organism by the action of substances, such as enzymes, that are produced within the organism. Also called self-digestion. Debridement II-39 Dressing II-39 Symptoms of Local Infection II-39 7. Wound Care II-40 Preparation II-40 Controlling Bleeding II-40 Irrigation irrigation, in agriculture, artificial watering of the land. Although used chiefly in regions with annual rainfall of less than 20 in. (51 cm), it is also used in wetter areas to grow certain crops, e.g., rice. and Cleaning II-40 Closure II-40 Infection Control II-40 Common Misconceptions About Wound Care II-41 8. The Wound-Healing Process II-42 Phases of Wound Healing II-42 Injury II-42 Inflammatory Response II-42 Characteristics II-42 Coagulation Cascade Coagulation cascade The sequence of biochemical activities, involving clotting factors, that stop bleeding by forming a clot. Mentioned in: Fibrin Split Products, Partial Thromboplastin Time II-42 Vasodilation vasodilation /vaso·di·la·tion/ (-di-la´shun) 1. increase in caliber of blood vessels. 2. a state of increased caliber of blood vessels. II-43 Cellular Activity II-43 Debridement, Cell Growth and Healing II-44 Scarring II-44 Abnormal Scarring II-44 Fetal Wound Healing II-45 Factors Influencing Healing Time II-45 Risk Factors II-45 9. Cost Analysis II-46 Quality of Wound Care & Cost-Effective Wound Care II-46 Prices Likely to Remain Stable II-46 10. Channels of Distribution II-47 11. Product Introductions/Innovations II-48 3M Launches 3M[TM] Tegaderm[TM] CHG CHG Change CHG Charge CHG Changed CHG Chlorhexidine Gluconate (aka chloraprep) CHG Centre Hospitalier Général (French: general hospital) CHG Come Holy Ghost (Catholicism) IV Securement Dressing II-48 Kinetic Concepts Unveils AtmosAir[R] V-Series Mattress Replacement System II-48 Smith & Nephew Unveils NPWT NPWT Negative Pressure Wound Therapy Products II-48 Beiersdorf Launches New Website II-48 Smith & Nephew Introduces 2 Novel ALLEVYN Products II-48 Beiersdorf Unveils Hansaplast EXTREME II-49 ConvaTec Introduces ConvaTec Moldable Technology[TM] Skin Barriers II-49 DelSite Bags FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Approval for GelSite[R] II-49 Derma Sciences Unveils Innovative Wound Care Product II-49 Medline Introduces Advanced Wound Care Packaging System II-49 Ortec Files PMA PMA (papillary-marginal-attached), n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation. PMA Progressive muscular atrophy for Cryo-preserved OrCel[R] Indication II-50 Advanced BioHealing Introduces Dermagraft[R] Wound Care Solution II-50 Argentum Medical Unveils Silverlon[R] Calcium Alginate Dressings calcium alginate dressing Wound care A wound dressing used to manage exudates in partial to full-thickness wounds, providing a moist environment for healing. See Wound care. II-50 Johnson & Johnson Unveils SURGIFOAM[TM] II-50 Medline Unveils PictZar[R] Wound Measurement Software II-50 Angiotech Introduces New Wound Care Solution II-51 US Scientist Designs Innovative Bandage System II-51 US Scientists Invent Unique Wound Dressing Solution II-51 Smith & Nephew Introduces ALLEVYN Wound Care Solutions in Europe II-51 3M Introduces Steri-Strip S Surgical Skin Closure II-51 Coloplast Designs Fistula fistula (fĭs`ch  lə), abnormal, usually ulcerous channellike formation between two internal organs or between an internal organ and the skin. & Wound Management System II-52 Johnson & Johnson
Unveils FlexTip Applicator ap·pli·ca·torn. An instrument for applying something, such as a medication. applicator, n a device for applying medication; usually a slender rod of glass or wood, used with a pledget of cotton on the end. Tip for SURGIFLO[TM] II-52 Honeymark Introduces Wound Relief Lotion with Manuka Honey manuka honey (m  ·nōōˑ·k II-52 Wound Care
Strategies Introduces TriAssess[R] Premier 5.0 II-52 Onset Therapeutics
Releases Optase[TM] Wound Care Solution II-52 Coloplast Unveils New
Pain-Relieving Wound Care Solution II-53 Molnycke Unveils Mepitel[R]
Range of Wound Care Solutions II-53 Ark Releases Flaminal Wound-Care Gel
in UK II-53 US Scientist Designs Innovative Wound Care System II-53 US
Scientists Invent Novel Wound-Care Compounds II-53 US Scientists Unleash
Unique Wound Care Technique II-53 3M Unveils Absorbent absorbent /ab·sor·bent/ (-sor´bent)1. able to take in, or suck up and incorporate. 2. a tissue structure involved in absorption. 3. a substance that absorbs or promotes absorption. Clear Acrylic Wound Dressing II-54 3M Introduces Ag Mesh Wound Dressing Solution II-54 Denmark Scientist Invents Wound Care Device Comprising Chitosan II-54 Hydromer Unveils New Hydrogel Technology II-54 Medline Introduces Gentleheal[R] Atraumatic atraumatic /atrau·mat·ic/ (a?traw-mat´ik) not producing injury or damage. atraumatic not producing injury or damage. atraumatic adjective Without injury Super Absorbent Foam Dressing II-54 AMS AMS - Andrew Message System Unveils Improved ActivHeal Hydrocolloid hydrocolloid /hy·dro·col·loid/ (-kol´oid) a colloid system in which water is the dispersion medium. hy·dro·col·loid n. 1. A substance that forms a gel with water. 2. Wound Dressing II-55 AcryMed Develops Technology for Direct Oxygen Delivery to Wound Site II-55 Johnson & Johnson Launches New PRISMA PRISMA Probing Rotation and Interior of Stars: Microvariability and Activity PRISMA Preparation of Regional Industry for the Single Market (EU) Matrix Chronic Wound Dressing II-55 KCI KCI Kansas City International (airport) KCI Kennel Club of India KCI Key Club International KCI Korea Concrete Institute KCI Kitchener Collegiate Institute KCI Kids Central, Inc. KCI The Kitchen Collection, Inc. KCI Kodak Canada Inc. Introduces GranuFoam[R] Silver[TM] Dressings II-55 Medline Introduces XCell Cellulose Dressings II-55 3M Unveils Acrylic Dressing II-56 Smith & Nephew Launches GLADASE II-56 Beiersdorf AG Unveils Hansaplast Heat Pad II-56 Coloplast Unleashes Contreet Foam II-56 Ethicon Rolls Out Antibacterial Sutures II-56 Smith & Nephew Introduces Expanded ALLEVYN II-56 Alltracel Introduces SEAL-ON II-56 KCI Introduces V.A.C. Instill in·still v. To pour in drop by drop. in  stil·la tion n. Wound Therapy System II-56 Ark Therapeutics Launches Kerraboot
II-57 ConvaTec Launches CONVATEC AQUACEL Ag II-57 Medline Provides
SilvaSorb Range of Antimicrobial Silver Wound Dressings II-57 LAM IPM (1) (Impressions Per Minute) Generally refers to document scanners that scan both sides of the page at the same time. Thus, a scanner that scans at 100 ppm (pages per minute) can provide 200 ipm. See ppm and document scanner. Wound Gel Now Eligible For Medicare Reimbursement II-57 Coloplast
Introduces New Wound Care Product II-58 Tyco Introduces a Range of
Medical Adhesive Products II-58 Johnson & Johnson Introduces
Advanced Care Quick Stop Gauze gauze (gawz) a light, open-meshed fabric of muslin or similar material.absorbable gauze gauze made from oxidized cellulose. Pads II-58 Alltracel Develops Post Operative Adhesions Film II-58 Dumex Medical Introduces Online Service for Chronic Wound Management II-58 Johnson & Johnson Offers Skin Care Spray II-59 Novartis Introduces Savlon Activheal II-59 Cook Launches Oasis Wound Dressing II-59 Cohesion Launches Costasis II-59 12. Recent Industry Activity II-60 I-Flow Takes Over AcryMed II-60 Organogenesis Takes Over NanoMatrix II-60 Ortec Announces Name Change II-60 Derma Sciences and Biotest Collaborate II-60 Alltracel and ConvaTec Collaborate II-60 Derma Sciences to Supply MedAssets II-60 Organogenesis to Supply Novel Wound Healing Therapies to the US Army II-61 Smith & Nephew Takes Over BlueSky II-61 Derma Sciences Takes Over NutraMax's First Aid Business II-61 3M Takes Over Thai Based Neoplast II-62 Investor and Morgan Stanley  To comply with Wikipedia's , the introduction of this article needs a complete rewrite. Acquire Molnlycke Health Care
II-62 Smith & Nephew and Covalon Technologies Partner II-62 Derma
Sciences Enters Licensing Agreement with USC An abbreviation for U.S. Code. and QMT QMT Quilted Maple TopQMT Memorized List (File Name Extension) QMT Quality Management Team QMT Queen's Musical Theatre QMT Quality Measuring Tool QMT Quicken Memorized List QMT Quarter Mile Thunder (song) II-62 Coloplast Sets Up New Facility II-62 Innocoll Gains European Patents II-62 Diversified Clinical Services and Wound Care Centers to have Common Ownership II-63 Smith & Nephew and UDL UDL Universal Design for Learning UDL Universitat de Lleida (Spain) UDL Universal Data Link UDL Urban Debate League UDL Uniformly Distributed Load (mechanics, building trade) UDL User Defined Logic Laboratories Sign distribution Pact II-63 DelSitech and Bayer Ink Licensing Pact II-63 Summit Corporate Services Activities that combine or consolidate certain enterprise-wide needed support services, provided based on specialized knowledge, best practices, and technology to serve internal (and sometimes external) customers and business partners. Signs Agreement With Wound Care Technologies II-63 Nanopeutics And HemCon Medical Ink Pact II-63 Lescarden Calls Off Licensing Pact With Valeant II-64 Movianto To Store & Supply Smith & Nephew's Wound Management Solutions II-64 Healtheuniverse To Develop Living Wound Healing Solution II-64 TephaFlex Suture suture /su·ture/ (soo´cher) 1. sutura. 2. a stitch or series of stitches made to secure apposition of the edges of a surgical or traumatic wound. 3. to apply such stitches. 4. Gain FDA Approval II-64 FDA Certifies Veritas Collagen Matrix II-64 US FDA Approves CollaRx Gentamicin gentamicin /gen·ta·mi·cin/ (jen?tah-mi´sin) an aminoglycoside antibiotic complex isolated from bacteria of the genus Micromonospora, Phase II Trial II-64 Johnson & Johnson Overtakes Pfizer Consumer Healthcare II-65 Healagenics Acquires CambridgeMED's Assets II-65 Tyco Healthcare Adds Confluent con·flu·ent adj. 1. Flowing together; blended into one. 2. Merging or running together so as to form a mass, as sores in a rash. Surgical II-65 Anodyne anodyne /an·o·dyne/ (an´ah-din) 1. relieving pain. 2. a medicine that eases pain. an·o·dyne n. An agent that relieves pain. Medical Device Takes Over SenTech And AMF AMF ACE (Allied Command, Europe) Mobile Force AMF Autorité des Marchés Financiers (French) AMF Action Message Format AMF Arab Monetary Fund AMF Asian Monetary Fund AMF Autocrine Motility Factor II-65 Code Hennessy & Simmons Acquires Suture Express II-65 Triosyn Wears Safe Life Band II-65 Integra LifeSciences Integra LifeSciences Corporation, based in Plainsboro, New Jersey, is a leading medical technology company. Integra is a publicly traded company and is listed under the symbol IART. Acquires Kinetikos Medical II-65 Cambrex Acquires Cutanogen II-66 Secured Financial Network Acquires HEB HEB Hebrew HEB Hurst-Euless-Bedford (Texas) HEB Hot Electron Bolometer HEB Hindu Endowments Board (Singapore) HEB Here Everything's Better HEB High-Energy Beam HEB High Energy Biscuit II-66 CP Kelco Purchases Shandong Gold Millet Biological Products II-66 ULURU Integrates With Oxford Ventures II-66 Celltran And Xcellentis Merge II-66 Diversified Therapy and Praxis Clinical Services Merge II-66 U.S. Surgical Enters Into A Pact With Novation The substitution of a new contract for an old one. The new agreement extinguishes the rights and obligations that were in effect under the old agreement. A novation ordinarily arises when a new individual assumes an obligation to pay that was incurred by the original party II-66 Elder Health Care And Rye Pharmaceuticals Sign In-Licensing Pact II-67 Green Cross Bags Nivea Seoul's Distribution Contract II-67 HemCon Achieves Approval For Hemorrhage Control Bandages In Africa II-67 FDA Approves VERSAJET II-67 FDA Approves ALGICELL[TM] Ag Calcium Alginate Wound Dressing II-67 Kinetic Concepts' V.A.C. Freedom[R] Receives JAC JAC Journal of Antimicrobial Chemotherapy JAC Joint Astronomy Centre JAC Joint Advisory Committee (Board of Directors for SEI) JAC John Abbott College JAC Juvenile Assessment Center JAC Joint Analysis Center Certification II-67 US FDA Approves V.A.C Therapy System II-68 Cardium Takes Over the Wound Care Business of TRC TRC Noun (in South Africa) Truth and Reconciliation Commission: a commission which encourages people who committed human rights abuses or acts of terror during the apartheid era to reveal the truth about their crimes in return for immunity from prosecution II-68 Angiotech Acquires Quill for US$40 Million II-68 Angiotech Shells Out US$785 Million to Buy AMI II-68 Vascular Solutions Obtains FDA Nod for D-Stat Dry II-68 Dermisonics Introduces A-Wand Antiseptic Solution II-69 FDA Clearance for Innocoll's CollaGUARD[TM] Wound Care Solution II-69 Beiersdorf Shifts Production of Wound Care Products from Germany to Spain II-69 Covalon Receives Clearance for Wound Dressings Products II-69 Confluent Surgical Receives CE Mark for DuraSeal II-69 Covalon Obtains Patents for Medical Device Technology II-70 Avitar Inks Sales Deal with Dukal II-70 ThermoGenesis thermogenesis /ther·mo·gen·e·sis/ (-jen´e-sis) the production of heat, especially within the animal body.thermogenet´icthermogen´ic ther·mo·gen·e·sis n. Inks Sales Agreements with 2 European Companies II-70 ThermoGenesis Signs Sales Deals with 2 European Companies II-70 ThermoGenesis and Biomet Join Forces for Combined Technology Development II-70 Alkem to Sign JV Agreement with Oculus oculus (Latin: “eye”) In architecture, any of several elements resembling an eye, such as a round or oval window or the round opening at the top of some domes (see Pantheon). II-71 Oculus Gets FDA Approval for OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). Distribution of Dermacyn Wound Care II-71 Derma Sciences Renews Distribution Agreement with HealthPRO II-71 Biofisica Gets Approval to Market Wound Care Product in UK II-71 Coloplast to Pull-Down Shutters on UK Facility II-72 Carrington Enters into Marketing Agreements with Two Companies II-72 Argentum Signs Distribution Agreement with Rajat II-72 Misonix Signs Marketing Deal with Medline II-72 Ark Subsidiary Inks Sales and Promotion Agreement with HCL HCl hydrochloric acid. II-72 APH APH American Printing House for the Blind, Inc. APH Actual Production History APH Association of Personal Historians APH Antepartum Hemorrhage APH A Pleasurable Headache (Matthew Good Band community) Receives UK & Ireland Marketing Rights for Permitabs II-73 PuriCore Receives FDA Approval for Vashe II-73 HemCon Bags US$10 Million Supply Contract from the US Army II-73 AMS Receives European Patent for LiquiBand II-73 Extremity Innovations Joins Forces with CTT CTT Correios (Portuguese Postal Service) CTT Certified Technical Trainer CTT Charity Technology Trust CTT Cholesterol Treatment Trialists' (collaboration) CTT Common Task Training II-73 Smith & Nephew Signs Marketing Agreement with Lescarden II-74 FDA Approves Access' MuGardTM for Sale in the US II-74 AMS Joins Forces with AT3 and BSN II-74 Pegasus Biologics Receives FDA Approval for Its DermADAPTTM Biomatrix II-74 Ark Signs Licensing Agreement with Flen Pharma II-74 Cordis Takes Over Ensure Medical II-75 Texas A&M to Join Forces with MatrixDesign and DermaPlus II-75 Alltracel Signs JV Agreement with Elmarco II-75 ABH ABH Actual Bodily Harm ABH American Board of Hypnotherapy ABH Anywhere But Here (fan fiction mode) ABH Agentschap voor Buitenlandse Handel ABH Aviation Boatswain's Mate (aircraft handling) Acquires TransCyte[R] and Dermagraft[R] from Smith & Nephew II-75 Molnlycke Merges Operations with Medlock and Regent II-76 Derma Sciences Completely Acquires Western Medical for US$6.5 Million II-76 Nucryst Gains European Clearance for Marketing Acticoat Moisture Control II-76 ATG ATG antithymocyte globulin. lymphocyte immune globulin (antithymocyte globulin equine, ATG, ATG equine, LIG) Atgam Pharmacologic class: Immunoglobulin Therapeutic class: Immunosuppressant Forms Partnership with Flen Pharma to Market Flaminal[R] in UK II-76 3M Health Care Bags Global License for ClozeX Wound Closure Products II-77 DSI (Dynamic Systems Initiative) An umbrella term for a suite of Microsoft products that help manage the Windows environment in large enterprises. DSI was introduced in 2003. in Multiyear Agreement with Smith & Nephew II-77 DSI Inks Licensing Agreement with Comvita II-77 Smith & Nephew and Beiersdorf Sell BSN Medical to Montagu II-78 Onset Enters into Sales & Marketing Agreement with Granard II-78 Onset Therapeutics Establishes Company & Launches Wound Care Prescription Products II-78 Hapto Biotech Merges Operations with Ortec II-78 European Commission Approves Apax Partners' Take Over of Molnlycke II-79 Medline in Nationwide Agreement with Premier Purchasing Partners II-79 Cytomedix in Distribution Agreement with NWT NWT or N.W.T. abbr. Northwest Territories NWT Northwest Territories (of Canada) II-79 ArthroCare Acquires Assets & Businesses of Applied Therapeutics II-79 Yunnan & Alltracel in Agreement to Develop New Products II-80 FDA Clears Smith & Nephew's Acticoat Moisture Control Wound Dressing II-80 Derma Sciences Inks Distribution Agreement with Source Medical for Canadian Market II-80 Keratec in Partnership with Keraplast for Commercialization of Keratin keratin (kĕr`ətĭn), any one of a class of fibrous protein molecules that serve as structural units for various living tissues. The keratins are the major protein components of hair, wool, nails, horn, hoofs, and the quills of feathers. Technology II-81 FDA Approves Greystone's Epi-Max for Sale in the United States II-81 Amerinet in Agreement with Various Companies to Provide Advanced Wound Care Products II-81 Molnlycke Bags Contract to Deliver Wound Dressing Products to Novation II-81 J&J Expands Production Facilities by Establishing New Units in Brazil II-82 Quick-Med Collaborates with Johnson & Johnson Wound Management for Research Programs II-82 BioElectronics Bioelectronics A discipline in which biotechnology and electronics are joined in at least three areas of research and development: biosensors, molecular electronics, and neuronal interfaces. Establishes New Surgery and Wound Care Group II-82 Hydrogel in Strategic Alliance with Noble to Develop SilverSeal Wound Care Products II-82 Warburg Acquires and Merges CCS (1) (Common Channel Signaling) A communications system in which one channel is used for signaling and different channels are used for voice/data transmission. Signaling System 7 (SS7) is a CCS system, also known as CCS7. See SS7. Medical & MP TotalCare II-82 Brady Takes Over TruMed Technologies II-83 Tyco International Acquires Vivant II-83 aQva Pharmaceuticals Bags Distribution Rights for LAM IPM Wound Gel[TM] II-83 Costa Rican & Panamanian Governments Clear Sale of LAM IPM Wound Gel[TM] II-83 Johnson & Johnson Acquires CLOSURE Medical Corporation II-83 Medline in 3-Year Contract with Consorta for Wound-Care Products II-84 PhotoMedex Acquires ProCyte Corporation II-84 Closure Medical Receives CE Mark for OMNEX[TM] II-84 Smith & Nephew Acquires Versajet from HydroCision II-84 Bristol-Myers Squibb Snaps Up Acordis Speciality Fibres II-84 Biolight Bags Contract for Wound Care Equipment II-84 Smith & Nephew Terminates Supply Agreement of SANTYL II-85 Dow Corning Ties Up with Rohm & Haas II-85 Healthpoint Enters into an Agreement with IsoTis II-85 S&N Commences Wound Management Outcomes Tracking Division II-85 IsoTis SA Licenses Allox Cell-Based Product to Healthpoint Ltd II-85 Derma Sciences Pockets Dumex Medical II-85 Smith & Nephew Acquires Technology Rights from Advanced Tissue Sciences II-85 Medline Bags Contract from Premier to Supply Arglaes Wound Care Products II-86 AcryMed Awards Exclusive Marketing Rights to Medline II-86 Curative Receives Multi-Year Wound Care Management Contracts II-86 CliniCon Acquires Exclusive Software License Agreement with ConvaTec II-86 Smith & Nephew Joins Hands with NUCRYST II-87 S&N Obtains Westaim's Burn Business and Exclusive License for Wound Care Technology II-87 S&N Spins Off Traditional Wound Care Product Division II-87 CLOSURE Medical Offers J&J Wound Management Exclusive Technology License II-87 Medline Signs Pact with Consorta for Advanced Wound Care Products II-87 Sinclair Pharma Acquires Propharma II-87 Smith & Nephew Acquires BASF BASF Bar Association of San Francisco (since 1872; San Francisco, California) BASF Badische Anilin und Soda Fabrik (German chemical products company) BASF Builders Association of South Florida Pharma Collagenase collagenase /col·la·ge·nase/ (kah-laj´e-nas) an enzyme that catalyzes the hydrolysis of peptide bonds in triple helical regions of collagen. col·lag·e·nase n. Wound Care Product II-88 BioPharm Would Distribute ProCyte's Skin & Hair Products in the Middle East Markets II-88 Bayer Health Care Partners Signs Agreement with Molnlycke Health Care II-88 SmithKline Beecham in Pact with Human Genome Sciences Human Genome Sciences NASDAQ: HGSI is a biopharmaceutical corporation founded in 1992. Its stated purpose is to "discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs. II-88 Hydromer Signs Agreement with I-MED Pharma II-88 Chrysalis chrysalis (krĭs`əlĭs): see pupa. in a Pact with Abbott II-89 Chrysalis Signs Agreement with MicroMed Technology II-89 Creative BioMolecules This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules. This list is not necessarily complete or up to date - if you see an article that should be here but isn't (or one that shouldn't be here but is), please update the page Merges with Reprogenesis II-89 Genzyme Merges with Biomatrix II-89 ICN ICN International Council of Nurses. Pharmaceuticals Acquires Solco Basel AG II-89 Smith & Nephew Enters into Joint Venture with Beiersdorf II-89 Cook on a Restructuring Mode II-89 Amuchina Signs Licensing Agreement with ProCyte II-90 Merck KGaA Signs Licensing Agreement with ProCyte II-90 Haemacure Alliances with ZLB ZLB Zero Length Body ZLB Zero Length Bit II-90 Integra Life Sciences Alliances with J&J Medical II-90 PPL PPL - Polymorphic Programming Language. An interactive, extensible language, based on APL, from Harvard University. ["Some Features of PPL - A Polymorphic Programming Language", T.A. Standish, SIGPLAN Notices 4(8) (Aug 1969)]. Therapeutics PLC in Alliance with Smith & Nephew II-90 Chrysalis Signs Partnership Deal with OrthoLogic Corporation II-90 Cypros Pharmaceuticals Merges with RiboGene II-90 13. Focus on Select Players II-91 3M (US) II-91 Beiersdorf AG (Germany) II-91 Bristol-Myers Squibb (US) II-91 ConvaTec (US) II-91 BSN Medical GmbH & Co. KG (Germany) II-91 Carrington Laboratories (US) II-92 Coloplast A/S (Denmark) II-92 C.R. Bard Inc (US) II-92 Covidien Ltd (US) II-92 Derma Sciences Inc (US) II-93 FibroGen Inc (US) II-93 FibroGen Europe (Finland) II-94 Forticell Bioscience, Inc. (US) II-94 I-Flow Corp (US) II-94 AcryMed (US) II-94 Johnson & Johnson (US) II-94 Ethicon (US) II-95 CLOSURE Medical Corporation (US) II-95 Kensey Nash Corp (US) II-95 Kinetic Concepts, Inc. (US) II-96 LAM Pharmaceutical, Corp. (US) II-96 Medline (US) II-96 Molnlycke Health Care AB (Sweden) II-96 Organogenesis Inc (US) II-97 ProCyte Corporation (US) II-97 Smith & Nephew Plc (UK) II-97 Trumed Technologies (US) II-97 14. Global Market Perspective II-98 Table 3: World Recent Past, Current & Future Analysis for Wound Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-98 Table 4: World Long-term Projections for Wound Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-99 Table 5: World 10-Year Perspective for Wound Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-100 Table 6: World Recent Past, Current & Future Analysis for Antimicrobial Dressings by Geographic Region - US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-101 Table 7: World Long-Term Projections for Antimicrobial Dressings by Geographic Region - US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-102 Table 8: World 10-Year Perspective for Antimicrobial Dressings by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-103 Table 9: World Recent Past, Current & Future Analysis for Antimicrobial Dressings by Product Segment- Silver Antimicrobial Dressings and Non-Silver Antimicrobial Dressings Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-104 Table 10: World Long-Term Projections for Antimicrobial Dressings by Product Segment - Silver Antimicrobial Dressings and Non-Silver Antimicrobial Dressings Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-105 Table 11: World 10-Year Perspective for Antimicrobial Dressings by Product Segment- Percentage Breakdown of Dollar Sales for Silver Antimicrobial Dressings and Non-Silver Antimicrobial Dressings Markets for 2003, 2008, and 2012 II-105 Table 12: World Recent Past, Current & Future Analysis for Traditional Wound Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-106 Table 13: World Long-term Projections for Traditional Wound Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-107 Table 14: World 10-Year Perspective for Traditional Wound Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-108 Table 15: World Recent Past, Current & Future Analysis for Traditional Wound Care Products by Product Segment - Wound Management Products (Adhesive Bandages, Topical Ointments, and Gauzes); and Wound Closure Products (Internal Staplers, Skin Staplers, Surgical/Ligature Clips, Vascular Clips, and Sutures) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-109 Table 16: World Long-Term Projections for Traditional Wound Care Products by Product Segment - Wound Management Products (Adhesive Bandages, Topical Ointments, and Gauzes); and Wound Closure Products (Internal Staplers, Skin Staplers, Surgical/Ligature Clips, Vascular Clips, and Sutures) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-110 Table 17: World 10-Year Perspective for Traditional Wound Care Products by Product Segment - Percentage Breakdown of Dollar Sales for Wound Management Products (Adhesive Bandages, Topical Ointments, and Gauzes); and Wound Closure Products (Internal Staplers, Skin Staplers, Surgical/Ligature Clips, Vascular Clips, and Sutures) Markets for 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-111 Table 18: World Recent Past, Current & Future Analysis for Wound Management Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-112 Table 19: World Long-Term Projections for Wound Management Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-113 Table 20: World 10-Year Perspective for Wound Management Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-114 Table 21: World Recent Past, Current & Future Analysis for Wound Management Products by Product Segment - Adhesive Bandages, Topical Ointments, and Gauzes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-115 Table 22: World Long-Term Projections for Wound Management Products by Product Segment - Adhesive Bandages, Topical Ointments, and Gauzes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-115 Table 23: World 10-Year Perspective for Wound Management Products by Product Segment - Percentage Breakdown of Dollar Sales for Adhesive Bandages, Topical Ointments, and Gauzes for 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-116 Table 24: World Recent Past, Current & Future Analysis for Adhesive Bandages by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-117 Table 25: World Long-Term Projections for Adhesive Bandages by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-118 Table 26: World 10-Year Perspective for Adhesive Bandages by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-119 Table 27: World Recent Past, Current & Future Analysis for Topical Ointments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-120 Table 28: World Long-Term Projections for Topical Ointments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-121 Table 29: World 10-Year Perspective for Topical Ointments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-122 Table 30: World Recent Past, Current & Future Analysis for Gauzes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-123 Table 31: World Long-Term Projections for Gauzes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-124 Table 32: World 10-Year Perspective for Gauzes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-125 Table 33: World Recent Past, Current & Future Analysis for Wound Closure Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-126 Table 34: World Long-Term Projections for Wound Closure Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-127 Table 35: World 10-Year Perspective for Wound Closure Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-128 Table 36: World Recent Past, Current & Future Analysis for Wound Closure Products by Product Segment - Internal Staplers, Skin Staplers, Surgical/Ligature Clips, Vascular Clips, and Sutures Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-129 Table 37: World Long-Term Projections for Wound Closure Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-130 Table 38: World 10-Year Perspective for Wound Closure Products by Product Segment - Percentage Breakdown of Dollar Sales for Internal Staplers, Skin Staplers, Surgical/Ligature Clips, Vascular Clips, and Sutures Markets for 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-131 Table 39: World Recent Past, Current & Future Analysis for Internal Staplers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-132 Table 40: World Long-Term Projections for Internal Staplers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-133 Table 41: World 10-Year Perspective for Internal Staplers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-134 Table 42: World Recent Past, Current & Future Analysis for Skin Staplers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-135 Table 43: World Long-Term Projections for Skin Staplers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-136 Table 44: World 10-Year Perspective for Skin Staplers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-137 Table 45: World Recent Past, Current & Future Analysis for Surgical/Ligature Clips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-138 Table 46: World Long-Term Projections for Surgical/Ligature Clips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-139 Table 47: World 10-Year Perspective for Surgical/Ligature Clips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-140 Table 48: World Recent Past, Current & Future Analysis for Vascular Clips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-141 Table 49: World Long-Term Projections for Vascular Clips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-142 Table 50: World 10-Year Perspective for Vascular Clips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-143 Table 51: World Recent Past, Current & Future Analysis for Sutures by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-144 Table 52: World Long-Term Projections for Sutures by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-145 Table 53: World 10-Year Perspective for Sutures by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-146 Table 54: World Recent Past, Current & Future Analysis for Advanced Wound Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-147 Table 55: World Long-Term Projections for Advanced Wound Care Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-148 Table 56: World 10-Year Perspective for Advanced Wound Care Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-149 Table 57: World Recent Past, Current & Future Analysis for Advanced Wound Care Products by Product Segment - Moist Wound Healing Products (Alginate Dressings, Film Dressings, Foam Dressings, Hydrocolloid Dressings, and Hydrogel Dressings); Active Wound Healing Products (Skin Replacements, Collagen Dressings, and Growth Factors); Debriding Products; Cleansers; and Sealants Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-150 Table 58: World Long-Term Projections for Advanced Wound Care Products by Product Segment - Moist Wound Healing Products (Alginate Dressings, Film Dressings, Foam Dressings, Hydrocolloid Dressings, and Hydrogel Dressings); Active Wound Healing Products (Skin Replacements, Collagen Dressings, and Growth Factors); Debriding Products; Cleansers; and Sealants Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-151 Table 59: World 10-Year Perspective for Advanced Wound Care Products by Product Segment - Percentage Breakdown of Dollar Sales for Moist Wound Healing Products (Alginate Dressings, Film Dressings, Foam Dressings, Hydrocolloid Dressings, and Hydrogel Dressings); Active Wound Healing Products (Skin Replacements, Collagen Dressings, and Growth Factors); Debriding Products; Cleansers; and Sealants Markets for Years 2003, 2008, and 2012 (includes corresponding Graph/Chart) II-152 Table 60: World Recent Past, Current & Future Analysis for Moist Wound Healing Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-153 Table 61: World Long-Term Projections for Moist Wound Healing Pr To order this report: World Wound Care Products Market http://www.reportlinker.com/p092552/World-Wound-Care-Products-Market.html More market research reports here! |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion